Omnipod dash pods (GEN 4) 5PK 5S
Ended Awarded Last action
- Contract number
- SPE2DR26FL079
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,864
Award facts
- Contract value 100% obligated
- $12,863.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,863.91 to Amerisourcebergen Drug Corp on January 29, 2026, for OmniPod Dash Pods (Generation 4) in 5-packs, with an ultimate completion date of January 30, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order is issued under Amerisourcebergen Drug Corp's parent company, Cencora, Inc., which holds a significant $999.999 billion Indefinite Delivery Contract with DLA Troop Support Medical through December 2031, serving as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement needs through its DLA contracts, supplying a broad spectrum of medical products ranging from specialty medications to medical devices across multiple therapeutic domains. The OmniPod Dash Pods are continuous glucose monitoring and insulin delivery devices used for diabetes management, reflecting the company's role in supplying critical medical equipment and supplies to Department of Defense healthcare systems. This delivery order represents routine procurement activity under the parent company's comprehensive pharmaceutical prime vendor agreement, enabling efficient fulfillment of specific medical supply requirements across military treatment facilities and related federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FL079?
SPE2DR26FL079 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FL079 worth?
The government has obligated $12,864 on SPE2DR26FL079.
Is contract SPE2DR26FL079 an order under another contract?
Yes. SPE2DR26FL079 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FL079 competed?
The extent of competition for SPE2DR26FL079 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award